Search

Your search keyword '"G Depresseux"' showing total 63 results

Search Constraints

Start Over You searched for: Author "G Depresseux" Remove constraint Author: "G Depresseux"
63 results on '"G Depresseux"'

Search Results

1. Serum soluble interleukin 7 receptor is strongly associated with lupus nephritis in patients with systemic lupus erythematosus

2. Hand Radiological Damage in Systemic Sclerosis: Comparison with a Control Group and Clinical and Functional Correlations

3. Treatment of early rheumatoid arthritis: A randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone

4. Interest of a Prescreening Questionnaire to Reduce the Cost of Bone Densitometry

5. Hematological changes in anorexia nervosa are correlated with total body fat mass depletion

6. OP0188 The Dose of Glucocorticoids Taken at One Year, but Not The Initial Dose Prescribed, Is An Independent Predictor of Damage Accrual in Lupus Nephritis

7. Predictive value of ACR core set parameters for the development of rheumatoid arthritis in patients with positive anti-cyclic citrullinated peptide antibodies and undifferentiated arthritis

8. A pilot study of mycophenolate mofetil combined to intravenous methylprednisolone pulses and oral low-dose glucocorticoids in severe early systemic sclerosis

9. SAT0163 Risk of Malignancy and Severe Infection in a Population of Rheumatoid Arthritis Patients Treated with Biologics or DMARDS

10. Correlation between baseline femoral neck marrow status and the development of femoral head osteonecrosis in corticosteroid-treated patients: a longitudinal study by MR imaging

11. Magnetic resonance imaging-detected avascular osteonecrosis in systemic lupus erythematosus: lack of correlation with antiphospholipid antibodies

12. Hematological changes in anorexia nervosa are correlated with total body fat mass depletion

13. THU0323 Subsettting Proliferative Lupus Nephritis According to the ISN/RPS Classification Does not Provide Valuable Prognostic Information

16. IRM dynamique de perfusion du poignet dans l’evaluation du traitement de la polyarthrite rhumatoide precoce

17. Comparison of sodium fluoride + calcium with intravenous pamidronate in the therapy of glucocorticoid-induced osteoporosis

21. Severe trabecular and cortical bone loss in systemic lupus erythematosus (SLE): The respective roles of disease and corticosteroids (CS)

22. Efficacy of therapy of involutional osteoporosis with disodium monofluorophosphate and calcium

23. The effect of low dosage glucocorticoids on bone mass in rheumatoid arthritis: a cross-sectional and a longitudinal study using single photon absorptiometry

24. Non-hormonal treatment of osteoporosis

25. [Metabolic investigation of a population of institutionalized epileptics (author's transl)]

26. Effects of two different exercise programs on chronic fatigue in lupus patients.

27. Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis.

28. Prognosis of proliferative lupus nephritis subsets in the Louvain Lupus Nephritis inception Cohort.

29. The Belgian Systemic Sclerosis Cohort: correlations between disease severity scores, cutaneous subsets, and autoantibody profile.

30. Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial.

31. Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial.

32. Fibroblast growth factor-23 and parathyroid hormone are associated with post-transplant bone mineral density loss.

34. The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide.

35. A pilot study of mycophenolate mofetil combined to intravenous methylprednisolone pulses and oral low-dose glucocorticoids in severe early systemic sclerosis.

36. Dual energy x-ray absorptiometry-based assessment of male patients using standardized bone density values and a national reference database.

37. Correlation between baseline femoral neck marrow status and the development of femoral head osteonecrosis in corticosteroid-treated patients: a longitudinal study by MR imaging.

38. Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project".

39. Inulin and fructo-oligosaccharides differ in their ability to enhance the density of cancellous and cortical bone in the axial and peripheral skeleton of growing rats.

40. (18)F-fluoride PET for monitoring therapeutic response in Paget's disease of bone.

41. Oral pamidronate prevents high-dose glucocorticoid-induced lumbar spine bone loss in premenopausal connective tissue disease (mainly lupus) patients.

42. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.

43. Evaluation of proposals of Belgian Social Security Institute for reimbursement of bone densitometry tests. Toward a cost-effective strategy for osteoporosis screening?

44. Evaluation of bone mineral density after renal transplantation under a tacrolimus-based immunosuppression: a pilot study.

45. Relapses of lupus nephritis: incidence, risk factors, serology and impact on outcome.

46. Lessons from the "Euro-Lupus Cohort".

47. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.

48. Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation.

49. Evaluation of the simple calculated osteoporosis risk estimation (SCORE) in a sample of white women from Belgium.

50. Osteoporosis after organ transplantation.

Catalog

Books, media, physical & digital resources